GH Stock Analysis: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$114.04
3.56 (3.22%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 19, 2026
18d
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $114.04, which is considered extended relative to its 30-day fair value range of $103.29 to $113.90.
Technical Outlook: Technically, GH is in a strong uptrend. Immediate support is located at $105.78, while resistance sits at $120.74. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $122.14 (+10.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GH is in a strong uptrend. Immediate support is located at $105.78, while resistance sits at $120.74. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $122.14 (+10.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$103.29 -
$113.90
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
53.7%
Protect Your Profits
Holding GH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading below Wall St target ($122.14)
Fair Price Analysis
30-Day Fair Range
$103.29 -
$113.90
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$105.78
Resistance Level
$120.74
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-76.74
Wall Street Target
$122.14
(+10.6%)
Revenue Growth (YoY)
38.5%
Profit Margin
-44.2%
Last updated: January 30, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Myrtle S Potter
SELL
26 shares
2025-10-17
Musa Tariq
SELL
116 shares
2025-10-17
Musa Tariq
SELL
116 shares
2025-09-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$261 | 59 HOLD |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
